BioSculpture Technology, Inc.'s Qualified Tier 2 Regulation A Offering
July 17, 2016
IPO to commericalize disruptive minimally invasive treatment of obesity, metabolic syndrome, and type 2 diabetes.

Bioscupture Technology, Inc. files Form 1-A for tier 2 Reg. A Offering to commericialize its minimally invasive treatment ...

Medical Video depicting Endoscopic Visceral Lipectomy Procedure - laparoscopic procedure for the removal of visceral or "belly" fat as a minimally invasive treatment of obesity, metabolic syndrome, and type 2 diabetes mellitus:

Highlights of Investor Presentation:





Full Investor Presentation:






More from BioSculpture Technology, Inc.'s Qualified Tier 2 Regulation A Offering
The most important insight of the day
Get the Harvest Daily Digest newsletter.